XML 57 R2.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Income (Unaudited) (USD $)
In Thousands, except Per Share data
 3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Net sales $ 521,656 $ 467,662 $ 1,006,777 $ 921,896
Cost of goods sold 228,520 199,354 436,030 396,461
Gross profit 293,136 268,308 570,747 525,435
Selling, general and administrative expense 176,740 156,270 344,503 309,887
Research and development expense 48,210 43,862 90,940 84,125
Income from operations 68,186 68,176 135,304 131,423
Interest expense 12,041 14,325 28,807 28,769
Foreign exchange losses, net 2,744 1,014 5,786 797
Other (income) expense, net (4,418) (2,517) (5,369) (3,316)
Income before income taxes 57,819 55,354 106,080 105,173
Provision for income taxes (17,797) (16,833) (33,120) (31,260)
Net income including noncontrolling interests 40,022 38,521 72,960 73,913
Net loss (income) attributable to noncontrolling interests 26 (564) 127 (1,095)
Net income attributable to Bio-Rad $ 40,048 $ 37,957 $ 73,087 $ 72,818
Basic earnings per share:        
Net income per share basic attributable to Bio-Rad $ 1.43 $ 1.37 $ 2.61 $ 2.64
Weighted average common shares - basic 28,014 27,606 27,959 27,575
Diluted earnings per share:        
Net income per share diluted attributable to Bio-Rad $ 1.41 $ 1.35 $ 2.57 $ 2.59
Weighted average common shares - diluted 28,495 28,125 28,443 28,097